Subscribe To
Kronos Bio Presents Positive Preliminary Data from Phase 1 Dose Escalation Portion of Phase 1/2 KB-0742 Study at AACR-NCI-EORTC
Demonstrated on-mechanism, single agent anti-tumor activity in heavily pre-treated patients with transcriptionally addicted solid tumors Showed manageable safety profile, with no grade 3/4 neutropenia, dose proportional exposure, dose-dependent target engagement, and 24-hour plasma half-life Dose escalation continues; dosing of patients at the 80 mg dose level is ongoing Enrollment ongoing in dose expansion phase in MYC-dependent […] The post Kronos Bio Presents Positive Preliminary Data from Ph...
Read More
Content Topics
Kronos
Presents
Positive
Preliminary
Data
From
Phase
Dose
Escalation
Portion
Kb 0742
Aacr nci eortc
Forex
Posted: Oct 13 2023, 16:30
Author Name: forextv
Views: 091990